Table 4.

Stratified prevalence of lifetime use of different CAM categories

	Lifetime use in % (95% CI)
	CAM category 1	CAM category 2	CAM category 3	CAM category 4	CAM category 5
Sex
Male	26.5 (19.6–34.4)	25.9 (19.0–33.7)	15.7 (10.1–22.8)	15.0 (9.5–22.0)	2.9 (0.8–7.4)
Female	28.2 (15.0–44.9)	14.3 (4.8–30.3)	25.0 (12.1–42.2)	16.7 (6.4–32.8)	5.7 (0.7–19.2)
Age groups (in years)
18–24	31.6 (19.9–45.2)	23.2 (13.0–36.4)	10.7 (4.0–21.9)	14.3 (6.4–26.2)	0 (0.0–0.0)
25–34	26.5 (16.5–38.6)	23.5 (14.1–35.4)	17.2 (8.9–28.7)	13.8 (6.5–24.7)	1.6 (0.0–8.8)
≥ 35	23.0 (13.2–35.5)	24.1 (13.9–37.2)	25.0 (14.4–38.4)	18.2 (9.1–30.9)	8.9 (3.0–19.6)
Diagnoses
Other ASD diagnosis	29.5 (19.7–40.9)	27.0 (17.4–38.6)	18.3 (10.1–29.3)	19.7 (11.2–30.9)	3.0 (0.4–10.4)
Asperger syndrome	25.0 (17.2–34.3)	21.3 (14.0–30.2)	17.1 (10.5–25.7)	12.4 (6.8–20.2)	3.8 (1.1–9.6)
Intellectual functioning
IQ < 85	34.0 (21.5–48.3)	25.0 (13.6–39.6)	18.8 (8.9–32.6)	20.8 (10.5–35.0)	2.2 (0.1–11.8)
IQ ≥ 85	23.8 (16.5–32.3)	19.8 (13.1–28.1)	16.9 (10.7–25.0)	12.7 (7.3–20.1)	3.4 (0.9–8.5)
Level of education
Low	32.1 (19.9–46.3)	31.4 (19.1–45.9)	18.4 (8.8–32.0)	22.4 (11.8–36.6)	4.4 (0.5–15.2)
Medium	26.5 (14.9–41.1)	24.5 (13.3–38.9)	15.2 (6.3–28.9)	17.0 (7.6–30.8)	4.3 (0.5–14.8)
High	23.8 (15.1–34.4)	18.3 (10.6–28.4)	18.5 (10.8–28.7)	10.0 (4.4–18.8)	2.5 (0.3–8.7)
Overall	26.9 (20.7–33.9)	23.6 (17.7–30.5)	17.6 (12.3–24.1)	15.3 (10.4–21.5)	3.5 (1.3–7.5)